FDG-PET is Superior to Gallium Scintigraphy in Staging and More Sensitive in the Follow-up of Patients with de novo Hodgkin Lymphoma: A Blinded Comparison

References

• Wylie, B.R., Southee, A.E., Joshua, D.E., McLaughlin, A.F., Gibson, J., Hutton, B.F., et al. (1989) "Gallium scanning in the management of mediastinal Hodgkin's disease", European Journal of Haematology, 42, 344–347.
   PubMed Web of Science ®Google Scholar
• Salloum, E., Brandt, D.S., Caride, V.J., Cornelius, E., Zelterman, D., Schubert, W., etal. (1997) "Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients", Journal of Clinical Oncology, 15, 518— 527.
   Google Scholar
• King, S.C., Reiman, R.J. and Prosnitz, L.R. (1994) "Prognostic importance of restaging gallium scans following induction che-motherapy for advanced Hodgkin's disease", Journal of Clinical Oncology, 12, 306–311.
   Google Scholar
• Coiffier, B. (1999) "How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin's lymphoma patients?", Annals of Oncology, 10, 1141–1143.
   Google Scholar
• Weihrauch, M.R., Re, D., Scheidhauer, K., Ansen, S., Dietlein, M., Bischoff, S., et al. (2001) "Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease", Blood, 98, 2930 — 2934.
   Google Scholar
• Moog, F., Bangerter, M., Diederichs, C.G., Guhlmann, A., Merkle, E., Frickhofen, N., et al. (1998) "Extranodal malignant lymphoma: detection with FDG PET versus CT", Radiology, 206, 475–481.
   Google Scholar
• Carr, R., Barrington, S.F., Madan, B., O'Doherty, M.J., Saunders, C.A., van der Walt, J., et al. (1998) "Detection of lymphoma in bone marrow by whole-body positron emission tomography", Blood, 91, 3340— 3346.
   Google Scholar
• Moog, F., Bangerter, M., Kotzerke, J., Guhlmann, A., Frickhofen, N. and Reske, S.N. (1998) "18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow", Journal of Clinical Oncology, 16, 603–609.
   PubMed Web of Science ®Google Scholar
• Harris, N.L., Jaffe, ES., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., et al. (1999) "World Health Organization classification of neoplastic diseases of the hemato-poietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997", Journal of Clinical Oncology, 17, 3835 — 3849.
   Google Scholar
• Friedberg, J.W. (2002) "Staging and pre-treatment evaluation of Hodgkin's disease". In Malignant Lymphomas, edited by M.L. Grossbard. Pp 356— 373. London: BC Decker Inc.
   Google Scholar
• Cutler, P.D. and Xu, M. (1996) "Strategies to improve 3D whole-body PET image reconstruction", Physics Medicine Biology, 41, 1453 — 1467.
   Google Scholar
• Hudson, H.M. and Larkin, R.S. (1996) "Accelerated image reconstruction using ordered subsets of projection data", IEEE Translational Medical Imaging, 13, 601 — 609.
   Web of Science ®Google Scholar
• Kaplan, E. and Maier, P. (1958) "Nonparametric estimation from incomplete observations", Journal of the American Statistical Association, 53, 457–481.
   Web of Science ®Google Scholar
• Hagemeister, F.B., Fesus, S.M., Lamki, L.M. and Haynie, T.P. (1990) "Role of the gallium scan in Hodgkin's disease", Cancer, 65, 1090— 1096.
   PubMed Web of Science ®Google Scholar
• Blackwell, E.A., Joshua, D.E., McLaughlin, A.F., Green, D., Kronenberg, H. and May, J. (1986) "Early supradiaphragmatic Hodgkin's disease. High-dose gallium scanning obviates the need for staging laparotomy", Cancer, 58, 883–885.
   Google Scholar
• Delcambre, C., Reman, O., Henry-Amar, M., Peny, A.M., Macro, M., Cheze, S., et al. (2000) "Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy", European Journal of Nuclear Medicine, 27, 176 — 184.
   Google Scholar
• Stomper, P.C., Cholewinski, S.P., Park, J., Bakshi, S.P. and Barcos, M.P. (1993) "Abdominal staging of thoracic Hodgkin disease: CT-lymphangiography-Ga- 67 scanning correlation", Radiology, 187, 381— 386.
   Google Scholar
• Hagemeister, F.B., Purugganan, R., Podoloff, D.A., Hess, M., Rodriguez, M.A., McLaughlin, P., et al. (1994) "The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy", Annals of Oncology, 5, 59–63.
   Google Scholar
• Front, D., Bar-Shalom, R., Mor, M., Haim, N., Epelbaum, R., Frenkel, A., et al. (1999) "Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy", Radiology, 210, 487–491.
   PubMed Web of Science ®Google Scholar
• Gasparini, M.D., Balzarini, L., Castellani, M.R., Tesoro Tess, J.D., Maffioli, L.S., Petrillo, R., et al. (1993) "Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma", Cancer, 72, 577–582.
   Google Scholar
• Tucker, R., Coel, M., Ko, J., Morris, P., Druger, G. and McGuigan, P. (2001) "Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management: first year's experi-ence in a clinical center", Journal of Clinical Oncology, 19, 2504 — 2508.
   PubMed Web of Science ®Google Scholar
• Hueltenschmidt, B., Sautter-Bihl, M.L., Lang, O., Maul, F.D., Fischer, J., Mergenthaler, H.G., et al. (2001) "Whole body positron emission tomography in the treatment of Hodgkin disease", Cancer, 91, 302 — 310.
   Google Scholar
• Talbot, J.N., Haioun, C., Rain, J.D., Meignan, M., Wioland, M., Misset, J.L., et al. (2001) "[18F]-FDG positron imaging in clinical management of lymphoma patients", Critical Reviews of Oncology and Hematology, 38, 193–221.
   PubMed Web of Science ®Google Scholar
• Bangerter, M., Moog, F., Buchmann, I., Kotzerke, J., Griessham-mer, M., Hafner, M., et al. (1998) "Whole-body 24189-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease", Annals of Oncology, 9, 1117–1122.
   PubMed Web of Science ®Google Scholar
• Shah, N., Hoskin, P., McMillan, A., Gibson, P., Lowe, J. and Wong, W.L. (2000) "The impact of FDG positron emission tomography imaging on the management of lymphomas", British Journal of Radiology, 73, 482–487.
   Google Scholar
• Partridge, S., Timothy, A., O'Doherty, M.J., Hain, S.F., Rankin, S. and Mikhaeel, G. (2000) "2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution", Annals of Oncology, 11, 1273 — 1279.
   Google Scholar
• Buchmann, I., Reinhardt, M., Elsner, K., Bunjes, D., Altehoefer, C., Finke, J., et al. (2001) "2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial", Cancer, 91, 889–899.
   PubMed Web of Science ®Google Scholar
• Jerusalem, G., Beguin, Y., Fassotte, M.F., Najjar, F., Paulus, P., Rigo, P., et al. (1999) "Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomogra-phy scan imaging", Blood, 94, 429–433.
   PubMed Web of Science ®Google Scholar
• Naumann, R., Vaic, A., Beuthien-Baumann, B., Bredow, J., Kropp, J., Kittner, T., et al. (2001) "Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma", British Journal of Haematology, 115, 793–800.
   PubMed Web of Science ®Google Scholar
• Maisey, N.R., Hill, M.E., Webb, A., Cunningham, D., Flux, G.D., Padhani, A., et al. (2000) "Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?", European Journal of Cancer, 36, 200–206.
   PubMed Web of Science ®Google Scholar
• Zinzani, P.L., Magagnoli, M., Chierichetti, F., Zompatori, M., Garraffa, G., Bendandi, M., et al. (1999) "The role of positron emission tomography (PET) in the management of lymphoma patients", Annals of Oncology, 10, 1181–1184.
   Google Scholar
• Wirth, A., Seymour, J.F., Ware, R., Wolf, M., Prince, M., Januszewicz H., et al. (2000) "Can F-18 fluorodeoxyglucose positron emission tomography replace gallium-67 scanning for staging for Hodgkins disease and non-Hodgkins lymphoma?", Proceedings of American Society of Clinical Oncology, 19, 10a.
   Google Scholar
• Kostakoglu, L., Leonard, J.P., Kuji, I., Coleman, M., Vallabhajosula, S. and Goldsmith, S.J. (2002) "Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma", Cancer, 94, 879 — 888.
   Google Scholar
• Wirth, A., Seymour, J.F., Hicks, R.J., Ware, R., Fisher, R., Prince, M., et al. (2002) "Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma", American Journal of Medicine, 112, 262–268.
   PubMed Web of Science ®Google Scholar
• Shen, Y.Y., Kao, A. and Yen, R.F. (2002) "Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma", Oncology Reports, 9, 321 —325.
   Google Scholar
• Romer, W., Hanauske, A.R., Ziegler, S., Thodtmann, R., Weber, W., Fuchs, C., et al. (1998) "Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluoro-deoxyglucose", Blood, 91, 4464–4471.
   Google Scholar
• Allal, A.S., Dulguerov, P., Allaoua, M., Haenggeli, C.A., El Ghazi el, A., Lehmann, W., et al. (2002) "Standardized uptake value of 2-[(18)f] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without che-motherapy", Journal of Clinical Oncology, 20, 1398–1404.
   PubMed Web of Science ®Google Scholar
• Kotzerke, J., Guhlmann, A., Moog, F., Frickhofen, N. and Reske, S.N. (1999) "Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma", European Journal of Nuclear Medicine, 26, 31–38.
   PubMedGoogle Scholar
• Wiedmann, E., Baican, B., Hertel, A., Baum, R.P., Chow, K.U., Knupp, B., et al. (1999) "Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease", Leukemia and Lymphoma, 34, 545 — 551.
   Google Scholar